Financial - Data & Stock Exchanges
Compare Stocks
5 / 10Stock Comparison
CME vs ICE vs CBOE vs NDAQ vs MKTX
Revenue, margins, valuation, and 5-year total return — side by side.
Financial - Data & Stock Exchanges
Financial - Data & Stock Exchanges
Financial - Data & Stock Exchanges
Financial - Capital Markets
CME vs ICE vs CBOE vs NDAQ vs MKTX — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Financial - Data & Stock Exchanges | Financial - Data & Stock Exchanges | Financial - Data & Stock Exchanges | Financial - Data & Stock Exchanges | Financial - Capital Markets |
| Market Cap | $104.07B | $88.45B | $35.47B | $50.59B | $5.43B |
| Revenue (TTM) | $6.52B | $12.64B | $4.71B | $8.22B | $849M |
| Net Income (TTM) | $4.24B | $3.30B | $1.10B | $1.91B | $310M |
| Gross Margin | 86.1% | 61.9% | 48.9% | 47.9% | 69.9% |
| Operating Margin | 64.9% | 38.7% | 32.1% | 28.4% | 41.2% |
| Forward P/E | 23.5x | 19.5x | 27.0x | 22.6x | 18.6x |
| Total Debt | $3.76B | $20.28B | $1.68B | $9.93B | $285M |
| Cash & Equiv. | $4.42B | $837M | $2.22B | $814M | $520M |
CME vs ICE vs CBOE vs NDAQ vs MKTX — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| CME Group Inc. (CME) | 100 | 157.1 | +57.1% |
| Intercontinental Ex… (ICE) | 100 | 160.6 | +60.6% |
| Cboe Global Markets… (CBOE) | 100 | 318.1 | +218.1% |
| Nasdaq, Inc. (NDAQ) | 100 | 225.4 | +125.4% |
| MarketAxess Holding… (MKTX) | 100 | 30.0 | -70.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CME vs ICE vs CBOE vs NDAQ vs MKTX
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CME is the #2 pick in this set and the best alternative if dividends is your priority.
- 3.8% yield, 6-year raise streak, vs ICE's 1.2%
ICE ranks third and is worth considering specifically for income & stability and sleep-well-at-night.
- Dividend streak 14 yrs, beta 0.33, yield 1.2%
- Lower volatility, beta 0.33, Low D/E 69.9%, current ratio 1.02x
- Beta 0.33, yield 1.2%, current ratio 1.02x
- Beta 0.33 vs NDAQ's 0.78, lower leverage
CBOE carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 15.1%, EPS growth 44.5%
- 463.6% 10Y total return vs NDAQ's 347.6%
- PEG 1.38 vs MKTX's 3.03
- 15.1% NII/revenue growth vs MKTX's 3.8%
Among these 5 stocks, NDAQ doesn't own a clear edge in any measured category.
MKTX is the clearest fit if your priority is bank quality.
- NIM 1.3% vs CBOE's 0.5%
- Lower P/E (18.6x vs 22.6x)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 15.1% NII/revenue growth vs MKTX's 3.8% | |
| Value | Lower P/E (18.6x vs 22.6x) | |
| Quality / Margins | Efficiency ratio 0.2% vs MKTX's 0.3% (lower = leaner) | |
| Stability / Safety | Beta 0.33 vs NDAQ's 0.78, lower leverage | |
| Dividends | 3.8% yield, 6-year raise streak, vs ICE's 1.2% | |
| Momentum (1Y) | +45.8% vs MKTX's -31.7% | |
| Efficiency (ROA) | Efficiency ratio 0.2% vs MKTX's 0.3% |
CME vs ICE vs CBOE vs NDAQ vs MKTX — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CME vs ICE vs CBOE vs NDAQ vs MKTX — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
MKTX leads in 2 of 6 categories
CME leads 1 • CBOE leads 1 • ICE leads 0 • NDAQ leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
CME leads this category, winning 4 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
ICE is the larger business by revenue, generating $12.6B annually — 14.9x MKTX's $849M. CME is the more profitable business, keeping 62.0% of every revenue dollar as net income compared to NDAQ's 21.8%.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $6.5B | $12.6B | $4.7B | $8.2B | $849M |
| EBITDAEarnings before interest/tax | $4.7B | $6.5B | $1.6B | $3.1B | $443M |
| Net IncomeAfter-tax profit | $4.2B | $3.3B | $1.1B | $1.9B | $310M |
| Free Cash FlowCash after capex | $4.4B | $4.3B | $1.2B | $2.0B | $236M |
| Gross MarginGross profit ÷ Revenue | +86.1% | +61.9% | +48.9% | +47.9% | +69.9% |
| Operating MarginEBIT ÷ Revenue | +64.9% | +38.7% | +32.1% | +28.4% | +41.2% |
| Net MarginNet income ÷ Revenue | +62.0% | +26.1% | +23.3% | +21.8% | +29.0% |
| FCF MarginFCF ÷ Revenue | +64.3% | +33.9% | +24.5% | +24.2% | +44.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +21.4% | +23.1% | +59.7% | +33.8% | +4.5% |
Valuation Metrics
MKTX leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 22.9x trailing earnings, MKTX trades at a 29% valuation discount to CBOE's 32.5x P/E. Adjusting for growth (PEG ratio), CBOE offers better value at 1.66x vs ICE's 3.05x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $104.1B | $88.4B | $35.5B | $50.6B | $5.4B |
| Enterprise ValueMkt cap + debt − cash | $103.4B | $107.9B | $34.9B | $59.7B | $5.2B |
| Trailing P/EPrice ÷ TTM EPS | 25.70x | 27.06x | 32.50x | 28.80x | 22.92x |
| Forward P/EPrice ÷ next-FY EPS est. | 23.49x | 19.48x | 27.00x | 22.65x | 18.63x |
| PEG RatioP/E ÷ EPS growth rate | 1.87x | 3.05x | 1.66x | 2.70x | 3.03x |
| EV / EBITDAEnterprise value multiple | 22.96x | 16.71x | 21.35x | 20.14x | 11.96x |
| Price / SalesMarket cap ÷ Revenue | 15.96x | 7.00x | 7.52x | 6.16x | 6.39x |
| Price / BookPrice ÷ Book value/share | 3.60x | 3.08x | 6.93x | 4.19x | 4.85x |
| Price / FCFMarket cap ÷ FCF | 24.82x | 20.62x | 30.76x | 25.44x | 14.51x |
Profitability & Efficiency
MKTX leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
MKTX delivers a 24.0% return on equity — every $100 of shareholder capital generates $24 in annual profit, vs $12 for ICE. CME carries lower financial leverage with a 0.13x debt-to-equity ratio, signaling a more conservative balance sheet compared to NDAQ's 0.81x. On the Piotroski fundamental quality scale (0–9), ICE scores 9/9 vs MKTX's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +15.3% | +11.6% | +23.0% | +15.9% | +24.0% |
| ROA (TTM)Return on assets | +2.2% | +2.3% | +12.2% | +6.4% | +15.3% |
| ROICReturn on invested capital | +10.2% | +7.5% | +17.9% | +8.1% | +18.1% |
| ROCEReturn on capital employed | +3.6% | +9.5% | +22.7% | +10.2% | +25.4% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 9 | 7 | 9 | 5 |
| Debt / EquityFinancial leverage | 0.13x | 0.70x | 0.33x | 0.81x | 0.25x |
| Net DebtTotal debt minus cash | -$666M | $19.4B | -$532M | $9.1B | -$235M |
| Cash & Equiv.Liquid assets | $4.4B | $837M | $2.2B | $814M | $520M |
| Total DebtShort + long-term debt | $3.8B | $20.3B | $1.7B | $9.9B | $285M |
| Interest CoverageEBIT ÷ Interest expense | 41.55x | 6.53x | 40.58x | 14.11x | 168.60x |
Total Returns (Dividends Reinvested)
CBOE leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CBOE five years ago would be worth $32,366 today (with dividends reinvested), compared to $3,822 for MKTX. Over the past 12 months, CBOE leads with a +45.8% total return vs MKTX's -31.7%. The 3-year compound annual growth rate (CAGR) favors CBOE at 36.4% vs MKTX's -18.6% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +9.1% | -2.1% | +36.8% | -7.6% | -14.1% |
| 1-Year ReturnPast 12 months | +4.6% | -10.4% | +45.8% | +14.6% | -31.7% |
| 3-Year ReturnCumulative with dividends | +71.4% | +50.8% | +153.6% | +67.4% | -46.0% |
| 5-Year ReturnCumulative with dividends | +64.5% | +43.4% | +223.7% | +70.4% | -61.8% |
| 10-Year ReturnCumulative with dividends | +284.9% | +225.3% | +463.6% | +347.6% | +38.3% |
| CAGR (3Y)Annualised 3-year return | +19.7% | +14.7% | +36.4% | +18.7% | -18.6% |
Risk & Volatility
Evenly matched — CME and CBOE each lead in 1 of 2 comparable metrics.
Risk & Volatility
CME is the less volatile stock with a -0.30 beta — it tends to amplify market swings less than NDAQ's 0.78 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CBOE currently trades 97.7% from its 52-week high vs MKTX's 65.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | -0.30x | 0.33x | -0.27x | 0.78x | -0.28x |
| 52-Week HighHighest price in past year | $329.16 | $189.35 | $346.48 | $101.79 | $232.84 |
| 52-Week LowLowest price in past year | $257.17 | $143.17 | $212.75 | $77.09 | $146.00 |
| % of 52W HighCurrent price vs 52-week peak | +87.1% | +82.5% | +97.7% | +87.4% | +65.6% |
| RSI (14)Momentum oscillator 0–100 | 44.1 | 38.8 | 75.2 | 52.6 | 26.8 |
| Avg Volume (50D)Average daily shares traded | 2.2M | 3.0M | 878K | 3.3M | 456K |
Analyst Outlook
Evenly matched — CME and ICE each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: CME as "Hold", ICE as "Buy", CBOE as "Hold", NDAQ as "Buy", MKTX as "Hold". Consensus price targets imply 28.8% upside for NDAQ (target: $115) vs -12.6% for CBOE (target: $296). For income investors, CME offers the higher dividend yield at 3.81% vs CBOE's 0.80%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Hold | Buy | Hold |
| Price TargetConsensus 12-month target | $320.25 | $195.71 | $296.00 | $114.60 | $195.60 |
| # AnalystsCovering analysts | 35 | 36 | 31 | 36 | 23 |
| Dividend YieldAnnual dividend ÷ price | +3.8% | +1.2% | +0.8% | +1.2% | +2.0% |
| Dividend StreakConsecutive years of raises | 6 | 14 | 10 | 13 | 12 |
| Dividend / ShareAnnual DPS | $10.92 | $1.93 | $2.71 | $1.04 | $3.13 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.3% | +1.6% | +0.3% | +1.2% | +7.7% |
MKTX leads in 2 of 6 categories (Valuation Metrics, Profitability & Efficiency). CME leads in 1 (Income & Cash Flow). 2 tied.
CME vs ICE vs CBOE vs NDAQ vs MKTX: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CME or ICE or CBOE or NDAQ or MKTX a better buy right now?
For growth investors, Cboe Global Markets, Inc.
(CBOE) is the stronger pick with 15. 1% revenue growth year-over-year, versus 3. 8% for MarketAxess Holdings Inc. (MKTX). MarketAxess Holdings Inc. (MKTX) offers the better valuation at 22. 9x trailing P/E (18. 6x forward), making it the more compelling value choice. Analysts rate Intercontinental Exchange, Inc. (ICE) a "Buy" — based on 36 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CME or ICE or CBOE or NDAQ or MKTX?
On trailing P/E, MarketAxess Holdings Inc.
(MKTX) is the cheapest at 22. 9x versus Cboe Global Markets, Inc. at 32. 5x. On forward P/E, MarketAxess Holdings Inc. is actually cheaper at 18. 6x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Cboe Global Markets, Inc. wins at 1. 38x versus MarketAxess Holdings Inc. 's 3. 03x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — CME or ICE or CBOE or NDAQ or MKTX?
Over the past 5 years, Cboe Global Markets, Inc.
(CBOE) delivered a total return of +223. 7%, compared to -61. 8% for MarketAxess Holdings Inc. (MKTX). Over 10 years, the gap is even starker: CBOE returned +463. 6% versus MKTX's +38. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CME or ICE or CBOE or NDAQ or MKTX?
By beta (market sensitivity over 5 years), CME Group Inc.
(CME) is the lower-risk stock at -0. 30β versus Nasdaq, Inc. 's 0. 78β — meaning NDAQ is approximately -358% more volatile than CME relative to the S&P 500. On balance sheet safety, CME Group Inc. (CME) carries a lower debt/equity ratio of 13% versus 81% for Nasdaq, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — CME or ICE or CBOE or NDAQ or MKTX?
By revenue growth (latest reported year), Cboe Global Markets, Inc.
(CBOE) is pulling ahead at 15. 1% versus 3. 8% for MarketAxess Holdings Inc. (MKTX). On earnings-per-share growth, the picture is similar: Nasdaq, Inc. grew EPS 60. 1% year-over-year, compared to -8. 5% for MarketAxess Holdings Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CME or ICE or CBOE or NDAQ or MKTX?
CME Group Inc.
(CME) is the more profitable company, earning 62. 0% net margin versus 21. 8% for Nasdaq, Inc. — meaning it keeps 62. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CME leads at 64. 9% versus 28. 4% for NDAQ. At the gross margin level — before operating expenses — CME leads at 86. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CME or ICE or CBOE or NDAQ or MKTX more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Cboe Global Markets, Inc. (CBOE) is the more undervalued stock at a PEG of 1. 38x versus MarketAxess Holdings Inc. 's 3. 03x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, MarketAxess Holdings Inc. (MKTX) trades at 18. 6x forward P/E versus 27. 0x for Cboe Global Markets, Inc. — 8. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NDAQ: 28. 8% to $114. 60.
08Which pays a better dividend — CME or ICE or CBOE or NDAQ or MKTX?
All stocks in this comparison pay dividends.
CME Group Inc. (CME) offers the highest yield at 3. 8%, versus 0. 8% for Cboe Global Markets, Inc. (CBOE).
09Is CME or ICE or CBOE or NDAQ or MKTX better for a retirement portfolio?
For long-horizon retirement investors, Cboe Global Markets, Inc.
(CBOE) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 27), 0. 8% yield, +463. 6% 10Y return). Both have compounded well over 10 years (CBOE: +463. 6%, NDAQ: +347. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CME and ICE and CBOE and NDAQ and MKTX?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: CME is a mid-cap income-oriented stock; ICE is a mid-cap quality compounder stock; CBOE is a mid-cap high-growth stock; NDAQ is a mid-cap quality compounder stock; MKTX is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.